The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome
Open accessAbstract
Although some reports have found an association between increasing HLA disparity between donor and recipient and fewer relapses after allogeneic blood or marrow transplantation (BMT), this potential benefit has been offset by more graft-versus-host disease (GVHD) and nonrelapse mortality (NRM). However, the type of GVHD prophylaxis might influence the balance between GVHD toxicity and relapse. The present study analyzed the impact of greater HLA disparity on outcomes of a specific platform for nonmyeloablative (NMA), HLA-haploidentical transplantation. A retrospective analysis was performed of 185 patients with hematologic malignancies enrolled in 3 similar trials of NMA, related donor, haploidentical BMT incorporating high-dose posttransplantation cyclophosphamide for GVHD prophylaxis. No significant association was found between the number of HLA mismatches (HLA-A, -B, -Cw, and -DRB1 combined) and risk of acute grade II-IV GVHD (hazard ratio [HR] = 0.89; P = .68 for 3-4 vs fewer antigen mismatches). More mismatching also had no detrimental effect on event-free survival (on multivariate analysis, HR = 0.60, P = .03 for 3-4 vs fewer antigen mismatches and HR = 0.55, P = .03 for 3-4 vs fewer allele mismatches). Thus, greater HLA disparity does not appear to worsen overall outcome after NMA haploidentical BMT with high-dose posttransplantation cyclophosphamide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220
Jagasia, M. H., Greinix, H. T., Arora, M., Williams, K. M., Wolff, D., Cowen, E. W., Palmer, J., Weisdorf, D., Treister, N. S., Cheng, G.-S., et al. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2014.12.001 · Cited by 5,459
1994 Consensus Conference on Acute GVHD Grading.
Przepiorka, D., Weisdorf, D., Martin, P., Hg, K., Beatty, P., Hows, J., & Thomas, E. D. (1995) · PubMed · Cited by 5,037
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Filipovich, A. H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J. R., Lee, S. J., Martin, P., Chien, J., Przepiorka, D., Couriel, D., et al. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.09.004 · Cited by 3,556
Chronic graft-versus-host syndrome in man
Shulman, H. M., Sullivan, K. M., Weiden, P. L., McDonald, G. B., Striker, G. E., Sale, G. E., Hackman, R., Tsoi, M.-S., Storb, R., & Donnall Thomas, E. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90380-0 · Cited by 2,406
Luznik, L., O'Donnell, P. V., Symons, H. J., Chen, A. R., Leffell, M. S., Zahurak, M., Gooley, T. A., Piantadosi, S., Kaup, M., Ambinder, R. F., et al. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.03.005 · Cited by 1,938
Self-citationLong-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., et al. (1996) · Nature · doi:10.1038/381434a0 · Cited by 1,455
Weng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300
Ruggeri, L., Mancusi, A., Capanni, M., Urbani, E., Carotti, A., Aloisi, T., Stern, M., Pende, D., Perruccio, K., Burchielli, E., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038687 · Cited by 616
Graft-versus-leukemia effects of transplantation and donor lymphocytes
Kolb, H.-J. (2008) · Blood · doi:10.1182/blood-2008-03-077974 · Cited by 582
Mielcarek, M., Martin, P. J., Leisenring, W., Flowers, M. E. D., Maloney, D. G., Sandmaier, B. M., Maris, M. B., & Storb, R. (2003) · Blood · doi:10.1182/blood-2002-08-2628 · Cited by 562
O'Donnell, P. V., Luznik, L., Jones, R. J., Vogelsang, G. B., Leffell, M. S., Phelps, M., Rhubart, P., Cowan, K., Piantadosi, S., & Fuchs, E. J. (2002) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.2002.v8.pm12171484 · Cited by 491
Self-citationPetersdorf, E. W., Gooley, T. A., Anasetti, C., Martin, P. J., Smith, A. G., Mickelson, E. M., Woolfrey, A. E., & Hansen, J. A. (1998) · Blood · doi:10.1182/blood.v92.10.3515 · Cited by 480
Drug-induced Immunological Tolerance
SCHWARTZ, R., & DAMESHEK, W. (1959) · Nature · doi:10.1038/1831682a0 · Cited by 479
Szydlo, R., Goldman, J. M., Klein, J. P., Gale, R. P., Ash, R. C., Bach, F. H., Bradley, B. A., Casper, J. T., Flomenberg, N., Gajewski, J. L., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1767 · Cited by 468
Memory CD4+ T cells do not induce graft-versus-host disease
Anderson, B. E., McNiff, J., Yan, J., Doyle, H., Mamula, M., Shlomchik, M. J., & Shlomchik, W. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17601 · Cited by 440
Anasetti, C., Beatty, P. G., Storb, R., Martin, P. J., Mori, M., Sanders, J. E., Donnall Thomas, E., & Hansen, J. A. (1990) · Human Immunology · doi:10.1016/0198-8859(90)90071-v · Cited by 338
Diaconescu, R., Flowers, C. R., Storer, B., Sorror, M. L., Maris, M. B., Maloney, D. G., Sandmaier, B. M., & Storb, R. (2004) · Blood · doi:10.1182/blood-2004-03-0804 · Cited by 322
Burroughs, L. M., O'Donnell, P. V., Sandmaier, B. M., Storer, B. E., Luznik, L., Symons, H. J., Jones, R. J., Ambinder, R. F., Maris, M. B., Blume, K. G., et al. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.08.014 · Cited by 266
Self-citationKawase, T., Morishima, Y., Matsuo, K., Kashiwase, K., Inoko, H., Saji, H., Kato, S., Juji, T., Kodera, Y., & Sasazuki, T. (2007) · Blood · doi:10.1182/blood-2007-02-072405 · Cited by 254
Alousi, A. M., Weisdorf, D. J., Logan, B. R., Bolaños-Meade, J., Carter, S., DiFronzo, N., Pasquini, M., Goldstein, S. C., Ho, V. T., Hayes-Lattin, B., et al. (2009) · Blood · doi:10.1182/blood-2009-03-212290 · Cited by 222
Self-citationHsu, K. C., Gooley, T., Malkki, M., Pinto-Agnello, C., Dupont, B., Bignon, J.-D., Bornhäuser, M., Christiansen, F., Gratwohl, A., Morishima, Y., et al. (2006) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2006.04.008 · Cited by 212
Ash, R. C., Horowitz, M. M., Gale, R. P., et al. (1991) · PubMed · Cited by 199
STRAUSS, G., OSEN, W., & DEBATIN, K.-M. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01777.x · Cited by 185
Zheng, H., Matte-Martone, C., Li, H., Anderson, B. E., Venketesan, S., Sheng Tan, H., Jain, D., McNiff, J., & Shlomchik, W. D. (2008) · Blood · doi:10.1182/blood-2007-08-109678 · Cited by 185
Kanda, Y. (2003) · Blood · doi:10.1182/blood-2003-02-0430 · Cited by 150
Cyclophosphamide-Induced Immunological Tolerance: an Overview
Mayumi, H., Umesue, M., & Nomoto, K. (1996) · Immunobiology · doi:10.1016/s0171-2985(96)80033-7 · Cited by 137
Morishima, Y., Yabe, T., Matsuo, K., Kashiwase, K., Inoko, H., Saji, H., Yamamoto, K., Maruya, E., Akatsuka, Y., Onizuka, M., et al. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.10.027 · Cited by 117
Eto, M., Mayumi, H., Tomita, Y., Yoshikai, Y., Nishimura, Y., Maeda, T., Ando, T., & Nomoto, K. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.5.1402 · Cited by 84
Donor CD4 T Cells Are Critical in Allogeneic Stem Cell Transplantation against Murine Solid Tumor
Kamiryo, Y., Eto, M., Yamada, H., Yajima, T., Harano, M., Takeuchi, A., Tatsugami, K., Hamaguchi, M., Naito, S., & Yoshikai, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2517 · Cited by 15
Cited by
Bashey, A., Zhang, X., Sizemore, C. A., Manion, K., Brown, S., Holland, H. K., Morris, L. E., & Solomon, S. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.3523 · Cited by 499
Self-citationWho is the best donor for a related HLA haplotype-mismatched transplant?
Wang, Y., Chang, Y.-J., Xu, L.-P., Liu, K.-Y., Liu, D.-H., Zhang, X.-H., Chen, H., Han, W., Chen, Y.-H., Wang, F.-R., et al. (2014) · Blood · doi:10.1182/blood-2014-03-563130 · Cited by 344
Luznik, L., O'Donnell, P. V., & Fuchs, E. J. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.09.005 · Cited by 336
Self-citationModern approaches to HLA-haploidentical blood or marrow transplantation
Kanakry, C. G., Fuchs, E. J., & Luznik, L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.128 · Cited by 330
Self-citationMcCurdy, S. R., Kanakry, J. A., Showel, M. M., Tsai, H.-L., Bolaños-Meade, J., Rosner, G. L., Kanakry, C. G., Perica, K., Symons, H. J., Brodsky, R. A., et al. (2015) · Blood · doi:10.1182/blood-2015-01-623991 · Cited by 303
Self-citation
Metadata
- Authors
- Kasamon, Y. L., Luznik, L., Leffell, M. S., Kowalski, J., Tsai, H.-L., Bolaños-Meade, J., Morris, L. E., Crilley, P. A., O'Donnell, P. V., Rossiter, N., Huff, C. A., Brodsky, R. A., Matsui, W. H., Swinnen, L. J., Borrello, I., Powell, J. D., Ambinder, R. F., Jones, R. J., & Fuchs, E. J.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 16
- Issue
- 4
- Pages
- 482-489
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W2072290737
- Cited by
- 281
- References
- 32
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.